The first participant has been enrolled in a two-part Phase 3 clinical trial testing IKT-001, an experimental treatment for ...

Patients with interstitial lung diseases (ILDs) who require supplemental oxygen are more than three times as likely to experience pulmonary hypertension (PH), according to new interim data from the ...

Columnist Jen Cueva explains why it's important to give grace to those living with chronic pain, who are often suffering in ...

In a large trial, the approved therapy Winrevair showed confirmed benefits for CpcPH-HFpEF, a type of PH associated with ...

Anumana’s AI-enabled algorithm for the early detection of pulmonary hypertension (PH) has been cleared for use by the FDA.

Cereno’s CS1 was well tolerated after one year in people with PAH in an expanded access program, with results consistent with ...

Now that her health has improved, columnist Jolie Lizana's greatest challenge is learning how to live fully within the limits ...

The proportion of people in the U.S. with PAH related to methamphetamine use increased by 93% between 2018 and 2022, a study shows.

The rare and severe lung disease called pulmonary hypertension (PH) affects the pulmonary arteries, causing high blood pressure. The pulmonary arteries transport the blood from the right heart ...

Treatment with mosliciguat, an inhaled medication given once-daily for pulmonary hypertension (PH), can safely reduce the resistance against blood flow in blood vessels of the lungs, according to a ...

Pulmonary hypertension (PH) is a rare but life-threatening disease that affects the pulmonary arteries, making them narrow and thick. The vessels, which are responsible for transporting blood from the ...